# Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea

> **NCT03059537** · PHASE4 · COMPLETED · sponsor: **Lars Kristian Munck** · enrollment: 71 (actual)

## Conditions studied

- Bile Acid Malabsorption

## Interventions

- **DRUG:** Oral chenodeoxycholic acid stimulation

## Key facts

- **NCT ID:** NCT03059537
- **Lead sponsor:** Lars Kristian Munck
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-13
- **Primary completion:** 2017-11-27
- **Final completion:** 2017-11-27
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059537, "Validation of Stimulated ∆FGF19 for Diagnosing Bile Acid Diarrhoea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03059537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*